au.\*:("For the AAB-001 201\/202 Investigators")
Results 1 to 1 of 1
Selection :
Effect of Immunotherapy With Bapineuzumab on Cerebrospinal Fluid Biomarker Levels in Patients With Mild to Moderate Alzheimer DiseaseBLENNOW, Kaj; ZETTERBERG, Henrik; RINNE, Juha O et al.Archives of neurology (Chicago). 2012, Vol 69, Num 8, pp 1002-1010, issn 0003-9942, 9 p.Article
